BTAI · BioXcel Therapeutics, Inc.
$0.90
-0.29 (-24.57%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company's history of significant losses, its negative cash flows from operations, its current debt obligations, potential near-term increased covenant-driven amortization payments under its Credit Agreement, its limited liquidity resources currently on hand, and its dependence on its ability to obtain additional financing to fund its operations after the current resources are exhausted, about which there can be no certainty, have resulted in management's assessment that there is substantial doubt about the Company's ability to continue as a going concern for a period of at least 12 months from the issuance date of the financial statements included in this Quarterly Report. Although the Company has developed and implemented certain plans, they will not mitigate the entity's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$28.59M
Shares
31.31M
Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.
Model estimate
Expected Aug 14 short interest
as of Aug 14
4,259,878
+1.1% vs reported
Short Squeeze Score
90/100
Short interest 13.5% of shares — P94
Days to cover 9.7 — P88
Price vs VWAP +13.4% — P86
Short-volume trend -4.2% — P34
Short interest change +4.2% — P69
Worst FTD 0.22% of shares — P90
Price spike +10
Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.
Short Interest History
| Settlement Date | Current Position | Previous Position | Change | Days to Cover |
|---|---|---|---|---|
|
2026-08-31
Scheduled
FINRA publishes Sep 10
|
— | — | — | — |
|
2026-08-14
Scheduled
FINRA publishes Aug 25
|
— | — | — | — |
| 2026-07-31 | 4,214,920 | 4,043,653 | +171,267 | 9.68 |
| 2026-07-15 | 4,043,653 | 3,662,908 | +380,745 | 1.64 |
| 2026-06-30 | 3,662,908 | 4,315,372 | -652,464 | 5.92 |
| 2026-06-15 | 4,315,372 | 3,525,975 | +789,397 | 6.85 |
| 2026-05-29 | 3,525,975 | 3,555,157 | -29,182 | 4.47 |
| 2026-05-15 | 3,555,157 | 4,243,441 | -688,284 | 5.66 |
| 2026-04-30 | 4,243,441 | 3,946,749 | +296,692 | 4.78 |
| 2026-04-15 | 3,946,749 | 3,312,077 | +634,672 | 3.08 |
| 2026-03-31 | 3,312,077 | 2,804,918 | +507,159 | 4.58 |
| 2026-03-13 | 2,804,918 | 1,876,148 | +928,770 | 1.00 |
| 2026-02-27 | 1,876,148 | 1,937,441 | -61,293 | 7.46 |
| 2026-02-13 | 1,937,441 | 1,527,067 | +410,374 | 5.61 |
| 2026-01-30 | 1,527,067 | 1,365,977 | +161,090 | 2.71 |
| 2026-01-15 | 1,365,977 | 1,030,339 | +335,638 | 1.91 |
| 2025-12-31 | 1,030,339 | 979,751 | +50,588 | 2.24 |
| 2025-12-15 | 979,751 | 909,508 | +70,243 | 2.05 |
| 2025-11-28 | 909,508 | 1,580,569 | -671,061 | 1.33 |
| 2025-11-14 | 1,580,569 | 1,402,142 | +178,427 | 2.21 |
| 2025-10-31 | 1,402,142 | 1,141,061 | +261,081 | 1.78 |
| 2025-10-15 | 1,141,061 | 1,590,112 | -449,051 | 1.00 |
| 2025-09-30 | 1,590,112 | 1,443,374 | +146,738 | 1.14 |
| 2025-09-15 | 1,443,374 | 4,045,812 | -2,602,438 | 1.00 |
| 2025-08-29 | 4,045,812 | 1,517,065 | +2,528,747 | 1.00 |
Showing 1–23 of 23 settlements
Key facts
CIK
1720893
CUSIP
09075P204
13F (30d)
46 filings
46 filers
Visit website
Investor relations